SS-31

SS-31 is a mitochondria-targeted peptide also known as elamipretide. This product page provides information about its molecular characteristics, scientific background, specifications and supporting documentation.

At Peptide Insight, customers can review these details before identifying the exact product formulation. Additionally, they can examine relevant research and distinguish approved medicines from independently supplied preparations.

SS-31 Product Overview

This compound consists of four amino acids and belongs to the mitochondria-targeted tetrapeptide family.

Researchers have studied its interaction with cardiolipin, a phospholipid within the inner mitochondrial membrane. This interaction helps scientists investigate mitochondrial structure and cellular energy processes.

However, research involving one formulation cannot establish the safety or effectiveness of another.

Explore our Peptide Products collection to view related listings and product information.

SS-31 Product Specifications

Accurate specifications help customers identify the exact material.

First, confirm the manufacturer’s chemical identification and product label. Next, check the available strength, formulation and packaging.

Product name: SS-31

Alternative name: Elamipretide

Classification: Mitochondria-Targeted Tetrapeptide

Peptide length: Four amino acids

Strength: Confirm from the actual label

Product form: Manufacturer confirmation required

Storage: Follow verified manufacturer instructions

Furthermore, check the batch number and expiration date.

Visit the Peptide Insight shop for additional product information.

Scientific Research and Clinical Development

Scientists have investigated elamipretide in studies involving mitochondrial function and Barth syndrome.

A published clinical trial examined its effects on patients with this rare genetic condition. Although the initial randomized phase did not meet its primary endpoints, researchers reported improvements during the longer open-label extension.

Additionally, a specific prescription formulation subsequently received accelerated approval for a defined Barth syndrome indication.

Read the published elamipretide clinical study for further information.

Product Quality and Documentation

First, verify the manufacturer’s specifications and chemical identity.

Next, examine any available certificate of analysis. Confirm that its batch information matches the actual product.

Moreover, review supporting records before making purity or testing claims.

A product photograph alone cannot establish authenticity, sterility or quality.

For more website information, visit the Peptide Insight homepage.

Safety and Regulatory Information

The approved prescription formulation and independently supplied research products are not automatically interchangeable.

Consequently, customers should verify the precise formulation, intended use and applicable regulatory requirements.

Finally, contact the supplier if essential specifications or supporting documentation remain unclear.